Remove medicinal-chemistry about-us
article thumbnail

What is the future of biologic medicines?

European Pharmaceutical Review

There are a lot of conjugated products in the clinical pipeline and novel conjugation partners and chemistries are being tried. Two trends that I expect to continue in the foreseeable future are the move towards precision medicine and the diversification of the biologics chemical structures.

99
article thumbnail

Outsourcing regulatory activities in pharma

European Pharmaceutical Review

1 Collectively, Europe and the US are anticipated to account for 60 percent of the global outsourcing regulatory affairs demand to 2032. Servier is active in cardiology, metabolic diseases, oncology, and neuroscience both in medicinal chemistry and biotechnology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Novel cancer therapeutic synthesised by Stanford researchers

European Pharmaceutical Review

Research published in the journal Nature Chemistry , shows how researchers from Stanford University in the US uncovered a promising new method to synthetically manufacture the compound tigilanol tiglate, named EBC-46, which could offer targeted medicine for cancer and other diseases.

article thumbnail

‘Endless possibilities’: the chemists changing molecules atom by atom

The Guardian - Pharmaceutical Industry

A new method called ‘skeletal editing’ offers a hugely simplified way to alter matter, paving the way for world-changing innovations in personalised medicine and sustainable plastics Ask Mark Levin what excites him about his work, and the associate professor of chemistry at the University of Chicago could double as a poet.

58
article thumbnail

CRISPR pioneers Doudna and Charpentier claim Nobel chemistry prize

pharmaphorum

Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9. There is enormous power in this genetic tool, which affects us all. The post CRISPR pioneers Doudna and Charpentier claim Nobel chemistry prize appeared first on.

101
101
article thumbnail

Machine-learning, robotics and biology to deliver drug discovery of tomorrow

pharmaphorum

Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment. Working together, the group will provide druggable chemistry against the entire in silico pipeline, offering new benchmarks of cost and time effectiveness over conventional methods of discovery.

article thumbnail

Psychedelic research: evaluating the fast-evolving regulatory roadmap

European Pharmaceutical Review

In the earlier statement, the regulatory agency noted that clinical research “…is a critical step in the generation of good quality evidence needed to better understand the potential health benefits and harms associated with the therapeutic use of psilocybin.” What sponsors should know about psychedelic drug development.